In 2023, Canada’s share of scientific publications among the world's 10% top-cited in Endocrinology, Diabetes and Metabolism stood at a particular value which is not provided here. According to forecasts, there is a consistent decline from 9.42% in 2024 to 8.5% in 2028, reflecting a downward trend. The year-on-year percentage change shows a gradual decrease annually, while the compound annual growth rate (CAGR) over these years reflects a continued reduction in Canada’s global competitive presence in these specialized scientific fields.
Future trends to watch for include examining factors contributing to this decline, such as research funding shortages or increased competition from other countries. Monitoring initiatives to boost research quality and collaborations could also provide insights into reversing this trend.
